Wulff, Hansen & Co’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,880
Closed -$346K 103
2025
Q1
$346K Sell
13,880
-767
-5% -$18.3K 0.32% 75
2024
Q4
$332K Sell
14,647
-1,655
-10% -$35.9K 0.31% 72
2024
Q3
$347K Sell
16,302
-1,688
-9% -$33.2K 0.31% 72
2024
Q2
$343K Hold
17,990
0.34% 67
2024
Q1
$347K Sell
17,990
-265
-1% -$5.25K 0.35% 67
2023
Q4
$380K Hold
18,255
0.42% 59
2023
Q3
$393K Buy
18,255
+2,688
+17% +$65.3K 0.46% 57
2023
Q2
$373K Sell
15,567
-3,715
-19% -$85.2K 0.42% 56
2023
Q1
$410K Hold
19,282
0.47% 58
2022
Q4
$315K Buy
19,282
+4,450
+30% +$66K 0.38% 59
2022
Q3
$208K Hold
14,832
0.26% 75
2022
Q2
$370K Buy
14,832
+4,018
+37% +$120K 0.42% 63
2022
Q1
$364K Hold
10,814
0.35% 69
2021
Q4
$351K Buy
+10,814
New +$356K 0.3% 70

Other funds holding FMS

Wulff, Hansen & Co's FMS Position: Q2 2025 in Review

Wulff, Hansen & Co sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 13,880 shares — an estimated $346K sold.

Wulff, Hansen & Co first reported a position in FMS in Q4 2021 and held it in 14 quarters. The position peaked at $410K in Q1 2023. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

  • Wulff, Hansen & Co reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
  • Wulff, Hansen & Co sold 13,880 Fresenius Medical Care shares in Q2 2025, an estimated $346K.
  • Wulff, Hansen & Co first reported a position in Fresenius Medical Care in Q4 2021 and held it in 14 quarters.
  • Wulff, Hansen & Co's Fresenius Medical Care position peaked at $410K in Q1 2023.
  • 207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on Wulff, Hansen & Co's 13F filing for Q2 2025, filed 12 Aug 2025.